Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Kindred Biosciences Initiates Pivotal Efficacy Study Of Tirnovetmab Monoclonal Antibody For Canine Atopic Dermatitis


Benzinga | Dec 22, 2020 08:32AM EST

Kindred Biosciences Initiates Pivotal Efficacy Study Of Tirnovetmab Monoclonal Antibody For Canine Atopic Dermatitis






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC